# Efficacy Study of Auriclosene Irrigation Solution on Urinary Catheter Patency

> **NCT02130518** · PHASE2 · UNKNOWN · sponsor: **NovaBay Pharmaceuticals, Inc.** · enrollment: 140 (estimated)

## Conditions studied

- Urinary Catheter Blockage and Encrustation

## Interventions

- **DRUG:** Auriclosene Irrigation Solution, 0.2%
- **DRUG:** Auriclosene Vehicle Solution

## Key facts

- **NCT ID:** NCT02130518
- **Lead sponsor:** NovaBay Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-09
- **Primary completion:** 2015-12
- **Final completion:** 2016-01
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2015-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02130518

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02130518, "Efficacy Study of Auriclosene Irrigation Solution on Urinary Catheter Patency". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02130518. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*